Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06869785. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized, Parallel Group, Non-inferiority Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab, Followed by Extended Treatment in Participants With Relapsing Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new dosage of ofatumumab compared to the approved dosage of ofatumumab followed by extended treatment in participants with relapsing multiple sclerosis.
Study identification
- NCT ID
- NCT06869785
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 196 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2025 (Actual)
- Primary completion
- Jan 28, 2026 (Actual)
- Completion
- Mar 23, 2030 (Estimated)
- Last update posted
- Aug 10, 2026
2025 – 2030
United States locations
- U.S. sites
- 61
- U.S. states
- 24
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Neurology Associates PC | Birmingham | Alabama | 35209 | — |
| Xenoscience Inc | Phoenix | Arizona | 85004 | — |
| Ctr for Neurology and Spine | Phoenix | Arizona | 85018 | — |
| Phoenix Neurological Associates | Phoenix | Arizona | 85018 | — |
| The Research and Education Inst of Alta Bates Summit Med Grp | Berkeley | California | 94705 | — |
| Fullerton Neuro and Headache Ctr | Fullerton | California | 92835 | — |
| University of California Irvine | Irvine | California | 92697 | — |
| CenExcel Clinical Research | Los Alamitos | California | 90720 | — |
| Velocity Clinical Trials | Los Angeles | California | 90057 | — |
| Regina Berkovich MD PhD Inc | West Hollywood | California | 90048 | — |
| CU Anschutz Med Campus | Aurora | Colorado | 80045 | — |
| Medstar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Neurology of Central FL Res Ctr | Altamonte Springs | Florida | 32714 | — |
| Neurology Offices Of South Florida | Boca Raton | Florida | 33428 | — |
| First Choice Neurology | Boca Raton | Florida | 33486 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Memorial Healthcare System | Hollywood | Florida | 33021 | — |
| Neurology Associates PA | Maitland | Florida | 32751 | — |
| UM Department Of Neurology | Miami | Florida | 33136 | — |
| Elite Clinical Research | Miami | Florida | 33144 | — |
| Aqualane Clinical Research | Naples | Florida | 34105 | — |
| AdventHealth | Orlando | Florida | 32804 | — |
| Orlando Health Clinical Trials | Orlando | Florida | 32806 | — |
| Neurology Associates of Ormond Beach | Ormond Beach | Florida | 32174 | — |
| Neurostudies Inc | Port Charlotte | Florida | 33952 | — |
| Tallahassee Neurological Clinic | Tallahassee | Florida | 32308 | — |
| Axiom Brain Health | Tampa | Florida | 33609 | — |
| University Of South Florida | Tampa | Florida | 33612 | — |
| Vero Beach Neurology | Vero Beach | Florida | 32960 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Atlanta NeuroScience Institute | Atlanta | Georgia | 30327 | — |
| Josephson Wallack Munshower Neurology PC | Indianapolis | Indiana | 46256 | — |
| Univ of Kansas Hosp and Med Ctr | Kansas City | Kansas | 66160 | — |
| Advent Neurology Clinic | Roeland Park | Kansas | 66205 | — |
| Neuro Medial Clinic of Central Louisiana | Alexandria | Louisiana | 71301 | — |
| Delricht Research | New Orleans | Louisiana | 70115 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Mid Atlantic Epilepsy and Sleep Ctr | Bethesda | Maryland | 20817-1807 | — |
| International Neurorehab Institute | Lutherville | Maryland | 21093 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202-2689 | — |
| Rochester Cent For Behavioral | Rochester Hills | Michigan | 48307 | — |
| WA Uni School Of Med | St Louis | Missouri | 63110 | — |
| Cleveland Clinic Foundation | Las Vegas | Nevada | 89106 | — |
| Hackensack University Medical Ctr | Hackensack | New Jersey | 07601 | — |
| South Shore Neurologic Associates | Patchogue | New York | 11772 | — |
| True North Neurology | Port Jefferson | New York | 11776 | — |
| Velocity Clinical Research | Raleigh | North Carolina | 27607 | — |
| Dayton Center for Neurological Disorders | Centerville | Ohio | 45459 | — |
| University Of Cincinnati | Cincinnati | Ohio | 45267 | — |
| OSU Wexner Medical Center | Columbus | Ohio | 43221 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107-5098 | — |
| Neurology Clinic PC | Cordova | Tennessee | 38018 | — |
| University of Tennessee Medical Ctr | Knoxville | Tennessee | 37920 | — |
| Sibyl Wray MD Neurology PC | Knoxville | Tennessee | 37922 | — |
| Carum Research | Dallas | Texas | 75231 | — |
| Saturn Research Solutions LLC | Plano | Texas | 75024 | — |
| Conquest Research | Vienna | Virginia | 22182 | — |
| Sentara Neuroscience Institute | Virginia Beach | Virginia | 23456 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
| MultiCare Research Institute for Research and Innovation | Tacome | Washington | 98405 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06869785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.